For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Avixgen Inc.

USPTO Granted Patents = 11

EPO Patents = 4

Forward Citations = 6

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Yi Yong Baek (7 out of 7 patents)

Hye Cheong Koo (5 out of 5 patents)

Jun Sub Choi (4 out of 4 patents)

4. Young Myeong Kim (3 out of 3 patents)

5. Min Jung Kim (3 out of 51 patents)

6. Ji Chang You (3 out of 5 patents)

7. Won Jin Park (2 out of 4 patents)

8. Dong Hyun Jo (2 out of 7 patents)

9. Jeong Hun Kim (2 out of 46 patents)

10. Chul Ho Lee (1 out of 57 patents)

11. Jun-Sub Choi (1 out of 6 patents)

12. Dong Keon Lee (1 out of 1 patent)

13. Gyoon Hee Han (1 out of 11 patents)

14. Doo Na Song (1 out of 1 patent)

15. Koo Hwan Chung (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 11702449 - Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient (2023-07-18),

2. 11547649 - Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients (2023-01-10),

3. 11208433 - Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same (2021-12-28),

4. 11141407 - Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative (2021-10-12),

5. 11040999 - Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient (2021-06-22),

6. 10821101 - Pharmaceutical composition for preventing or treating AIDS comprising rhodanine derivative (2020-11-03),

7. 10231971 - Pharmaceutical composition for preventing and treating dry eye diseases, containing imatinib as active ingredient (2019-03-19),

8. 10149888 - Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein (2018-12-11),

9. 9969771 - Tetrapeptide having effect of inhibiting VEGF-induced angiogenesis and use thereof (2018-05-15),

10. 9738905 - Vector for expressing NC protein of HIV and method for producing NC protein using the same (2017-08-22),

11. 8759536 - Rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients (2014-06-24),

AVIXGEN Inc. is a leading technology company specializing in the development of innovative software solutions. With a focus on advanced artificial intelligence and machine learning technologies, we provide cutting-edge solutions that empower businesses and transform industries. Our team of highly skilled professionals is dedicated to delivering high-quality software products tailored to meet the unique needs and challenges of our clients. Partnering with AVIXGEN Inc. enables businesses to stay ahead in the rapidly evolving digital landscape and drive growth.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

11 Patents

#321 in Seoul

#965 in South Korea

#50,356 in the World

Seoul, South Korea

Avixgen Inc.

Forward Citations = 6

18 inventors:

Yi Yong Baek (7 out of 7 patents)

Hye Cheong Koo (5 out of 5 patents)

Jun Sub Choi (4 out of 4 patents)

4. Young Myeong Kim (3 out of 3 patents)

5. Min Jung Kim (3 out of 51 patents)

Please report any incorrect information to support@idiyas.com

Loading…